Generate a tailored SOP for Dr. André Lieber. Improve your application with a focused, well-structured draft.
André Lieber is a Professor in the Division of Medical Genetics at the University of Washington. He received his MD from the Medical Institute in Moscow in 1987 and his PhD from Humboldt University in Berlin in 1992. He has extensive training in applied molecular medicine and translational biology, particularly focusing on gene therapy and human adenoviruses. His laboratory has contributed significantly to understanding the mechanisms of adenoviruses and their potential in cancer treatment through recombinant proteins. His innovative work includes developing new in vivo genome engineering techniques targeting hematopoietic stem cells for therapies against genetic blood disorders and infectious diseases. Lieber has published more than 157 original research articles and has an h-index of 60, highlighting his substantial contribution to the field. He has supervised numerous graduate and undergraduate students and is also an academic co-founder of several biotech companies. His research interests cover a range of applications within gene therapy, including treatments for hemoglobinopathies and leveraging in vivo methods for gene insertion and correction.
University of Washington • Seattle, WA
Leading research in gene therapy and medical genetics.
Standard Graduate School requirements for University of Washington apply to most departments listed unless specified otherwise by the program.